Latest filing published 23 Feb 2023 for Standard Biotools INC., €55k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +114.4%Entry US$3.19 · Close at T+365 US$6.84
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Vikram Jog: trading record in brief
All filings by Vikram Jog on record concern Standard Biotools Inc., in the capacity of finance chief. In total, 264 filings cover trades dated from 15 February 2011 to 21 February 2023.
Both buying and selling appear: 1 purchase worth €115k, against 51 sales worth €3.5M. The net balance comes to €3.4M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 41 share grants and 171 option exercises.
Most recently, on 23 February 2023, the filings show a share grant worth €55k in Standard Biotools Inc. The last insider purchase was made public on 8 August 2017, 3,379 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vikram Jog
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,707 shares@ US$2.038.0% of flowCommon StockSEC:0001162194-23-000008:5
- 16,666 shares0Common StockSEC:0001162194-23-000008:1
- 2,238 shares0Common StockSEC:0001162194-23-000008:2
- 2,391 shares0Common StockSEC:0001162194-23-000008:3
- 3,130 shares0Common StockSEC:0001162194-23-000008:4
- 50,000 shares0Common StockSEC:0001162194-23-000008:0
- 2,391 shares0Common StockSEC:0001162194-22-000101:1
- 2,237 shares0Common StockSEC:0001162194-22-000101:2
- 2,681 shares@ US$1.430.5% of flowCommon StockSEC:0001162194-22-000101:3
- 3,131 shares0Common StockSEC:0001162194-22-000101:0
- 2,681 shares@ US$1.560.6% of flowCommon StockSEC:0001162194-22-000093:3
- 2,390 shares0Common StockSEC:0001162194-22-000093:1
- 2,236 shares0Common StockSEC:0001162194-22-000093:2
- 3,130 shares0Common StockSEC:0001162194-22-000093:0
- 14,361 shares@ US$2.054.1% of flowCommon StockSEC:0001162194-22-000059:5
- 2,237 shares0Common StockSEC:0001162194-22-000059:1
- 2,391 shares0Common StockSEC:0001162194-22-000059:2
- 22,500 shares0Common StockSEC:0001162194-22-000059:3
- 12,522 shares0Common StockSEC:0001162194-22-000059:4
- 2,251 shares0Common StockSEC:0001162194-22-000059:0
- 2,237 shares0Common StockSEC:0001162194-22-000015:1
- 2,391 shares0Common StockSEC:0001162194-22-000015:2
- 2,825 shares@ US$3.621.3% of flowCommon StockSEC:0001162194-22-000015:3
- 2,251 shares0Common StockSEC:0001162194-22-000015:0
- 2,236 shares0Common StockSEC:0001162194-21-000094:1
25 of 262 declarations